Molecular Oncology, Vol 15, Iss 12, Pp 3299-3316 (2021) Molecular Oncology Terp, M G, Gammelgaard, O L, Vever, H, Gjerstorff, M F & Ditzel, H J 2021, ' Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer : combined targeting could improve outcomes ', Molecular Oncology, vol. 15, no. 12, pp. 3299-3316 . https://doi.org/10.1002/1878-0261.13046
NPJ breast cancer, vol 7, iss 1 Løkkegaard, S, Elias, D, Alves, C L, Bennetzen, M V, Lænkholm, A-V, Bak, M, Gjerstorff, M F, Johansen, L E, Vever, H, Bjerre, C, Kirkegaard, T, Nordenskjöld, B, Fornander, T, Stål, O, Lindström, L S, Esserman, L J, Lykkesfeldt, A E, Andersen, J S, Leth-Larsen, R & Ditzel, H J 2021, ' MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit ', npj Breast Cancer, vol. 7, no. 1, pp. 2 . https://doi.org/10.1038/s41523-020-00210-8 npj Breast Cancer, Vol 7, Iss 1, Pp 1-15 (2021) NPJ Breast Cancer Løkkegaard, S, Elias, D, Alves, C L, Bennetzen, M V, Lænkholm, A V, Bak, M, Gjerstorff, M F, Johansen, L E, Vever, H, Bjerre, C, Kirkegaard, T, Nordenskjöld, B, Fornander, T, Stål, O, Lindström, L S, Esserman, L J, Lykkesfeldt, A E, Andersen, J S, Leth-Larsen, R & Ditzel, H J 2021, ' MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit ', npj Breast Cancer, vol. 7, 2 . https://doi.org/10.1038/s41523-020-00210-8